✦ LIBER ✦

Phase I trial of bortezomib and dacarbazine in melanoma and soft tissue sarcoma

✍ Scribed by Andrew Poklepovic, Leena Youseffian, Mary Winning, Christine A. Birdsell, Nancy A. Crosby, Viswanathan Ramakrishnan, Marc S. Ernstoff, John D. Roberts

Book ID: 120966753
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 362 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-012-9913-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Phase I trial of bortezomib

Erratum to: Phase I trial of bortezomib and dacarbazine in melanoma and soft tissue sarcoma

✍ Andrew Poklepovic, Leena E. Youssefian, Mary Winning, Christine A. Birdsell, Nan 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 53 KB

Sorafenib and dacarbazine in soft tissue

Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience

✍ Vincenzi, Bruno; Silletta, Marianna; Schiavon, Gaia; Frezza, Anna Maria; Del Ves 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 358 KB

Phase II trial of merbarone in soft tiss

Phase II trial of merbarone in soft tissue sarcoma

✍ Eric H. Kraut; Jackie Bendetti; Stanley P. Balcerzak; James H. Doroshow 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 190 KB

Melanoma and soft tissue sarcoma in seve

Melanoma and soft tissue sarcoma in seven patients

✍ Judy E. Garber; Marcia K. Liepman; Ellen J. Gelles; Joseph M. Corson; Karen H. A 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 1 views

Seven patients with both melanoma and sarcoma were seen at the Dana Farber Cancer Institute (Boston, MA) over a 4-year period. Three had additional malignant neoplasms; one of these patients also had the hereditary cutaneous malignant melanoma, dysplastic nevus syndrome. These observations suggest t

Cryosurgical ablation of soft tissue sar

Cryosurgical ablation of soft tissue sarcomas : A phase I trial of feasibility and safety

✍ Lawrence R. Menendez; Matthew S. Tan; Milton T. Kiyabu; Sant P. Chawla 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB

## BACKGROUND. Cryosurgery is a therapeutic method of treating neoplastic tissue by freezing in situ to achieve devitalization. Cell death results from exposure to severe cold (below Ϫ40°C for at least 1 minute) as well as from the process of freezing and thawing, which disrupts cellular integrity.

Phase II trial of echinomycin in advance

Phase II trial of echinomycin in advanced soft tissue sarcomas

✍ Sarah A. Taylor; Barbara Metch; Stanley P. Balcerzak; Karl H. Hanson 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 232 KB

Thirty-four patients with advanced soft tissue sarcomas were entered in a phase II trial of echinomycin. Patients received 1.2 mg/m 2 intravenously (i.v.) weekly times four followed by a two week rest period. There were no objective responses. Dose limiting toxicity was gastrointestinal. Echinomycin